NTAGI approves Serum Institute’s Covovax for 12-17 age group
New Delhi | The National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax...
New Delhi | The National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax...
New Delhi | The World Health Organisation on Friday approved emergency use listing of Covid vaccine Covovax, produced by the Serum...
New Delhi | The CEO of Serum Institute of India, Adar Poonawala, on Friday expressed hope that another vaccine against Covid-19...
New Delhi | The Pune-based Serum Institute of India (SII) has begun manufacturing Novavax's protein-based vaccine Covovax, CEO Adar Poonawalla has...
Pune: In what could be a mega boost to the ongoing Covid-19 vaccination drive in India, the Serum Institute of India...